510(k) · Cleared
ClearedCurian Campy
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Meridian Bioscience, Inc. · LQP Campylobacter Spp.
Cleared on Dec 23, 2021 as substantially equivalent to K191456 (Techlab, Inc., 2019) after a 266-day review. Its family tree reaches back 1 generation to 2019.
- Decided
- Dec 23, 2021
- Review
- 266 days
- Class
- Class I
- Product code
- LQP
- Recalls
- None
- Predicates
- 1
Its longest line of descent runs back 1 generation to K191456 (2019). No later device cites it as a predicate yet.
- Root · 1 generation backK191456 Campylobacter Quik ChekTechlab, Inc. · 2019
- This deviceK210976 Curian CampyMeridian Bioscience, Inc. · 2021
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K191456 | Campylobacter Quik Chek | Techlab, Inc. | 2019 | — |
| 0 (this device) | K210976 | Curian Campy | Meridian Bioscience, Inc. | 2021 | — |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LQP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LQP device
- #1 K211342 Sofia 2 Campylobacter FIAscore 2.4 · 1 generation · no Class I recall
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K191456 | Campylobacter Quik ChekSummary page 4…pylobacter fetus serological reagents (21 CFR 866.3110, Product Code LQP) Predicate Device: CAMPYLOBACTER QUIK CHEK K191456 Device Description The Curian® Campy assay is a qualitative in vitro diagnostic test for the detection of Campylobacter-specifi… | 2019 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- Its one ancestor has no recall.
- 1 other device also cites its predicate K191456.
How does its category compare?
All LQP devicesLQP Campylobacter Spp.: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.
FDA decisions per year · LQP
2in 2021
2026 to Oct 25, outlined.
Median 510(k) review, days · LQP
Too few LQP 510(k)s in any year since 2007 to give a median.
Recalls per year · LQP
No recall names LQP since 2007.
Adverse event reports per year · LQP
No MAUDE report names LQP since 2007.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 2 | — | 0 | 0 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 0 | — | 0 | 0 |
| 2013 | 0 | — | 0 | 0 |
| 2014 | 0 | — | 0 | 0 |
| 2015 | 0 | — | 0 | 0 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 2 | — | 0 | 0 |
| 2019 | 2 | — | 0 | 0 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 2 | — | 0 | 0 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 0 |
| 2024 | 0 | — | 0 | 0 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
Curian Campy, for use with the Curian Analyzer, is a rapid, qualitative fluorescent immunoassay for the detection of a Campylobacter-specific antigen in human fecal specimens. Curian Campy is intended to detect C. jejuni, C. coli, C. upsaliensis, and C. lari in human stool from patients with signs and symptoms of gastroenteritis. The test is intended for use with unpreserved fecal specimens or preserved fecal specimens in transport media. Test results are to be used in conjunction with information available from the patient clinical evaluation and other diagnostic procedures. Curian Campy is intended to aid in the diagnosis of Campylobacter infection.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K210976 · printed Nov 6, 2026
Cite this page
510(k) Report. “K210976: Curian Campy.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K210976
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026